Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Selective Laser Trabeculoplasty for Primary Open Angle Glaucoma and Ocular Hypertension and Normal Tension Glaucoma in Ethnic Chinese Population - The Zhuiguangzhe Trial

NCT05902871 is registered in ClinicalTrials.gov with BelkinVision as lead sponsor.

NCT NCT05902871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05902871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Selective Laser Trabeculoplasty for Primary Open Angle Glaucoma and Ocular Hypertension and Normal Tension Glaucoma in Ethnic Chinese Population - The Zhuiguangzhe Trial
Lead sponsor
BelkinVision
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 11, 2024
Completion date
January 31, 2027
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

normal tension glaucoma, ocular hypertension, primary open angle glaucoma